Anti-gdf15 antibody and a dosage regimen for the treatment of cancer
RS68123B1Active Publication Date: 2026-06-30CATALYM GMBH +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- RS68123P0
- Authority / Receiving Office
- RS · RS
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-11-10
- Filing Date
- 2021-11-10
- Publication Date
- 2026-06-30
- Estimated Expiration
- 2041-11-10
Need to check novelty before this filing date? Find Prior Art
No text content released.